InvestorsHub Logo
Followers 4
Posts 430
Boards Moderated 0
Alias Born 12/08/2008

Re: zigzagman post# 117

Wednesday, 11/18/2009 5:10:40 PM

Wednesday, November 18, 2009 5:10:40 PM

Post# of 552
Poniard Pharmaceuticals, Inc. Endures Analyst Downgrade; PARD, ILMN, GENZ
Tuesday, 17 November 2009 06:40
Rodman & Renshaw gave the Biotechnology industry some bad news as it announced a downgrade on one of its stocks.
Poniard Pharmaceuticals, Inc. (PARD) [Chart - News - Analysis] was downgraded from Mkt Outperform » Mkt Perform on 11/17/2009---a negative sign for the stock that investors will have to endure. FYI, Rodman & Renshaw uses the following rating scale when analyzing stocks: Mkt Outperform, Mkt Perform, Mkt Underperform, Under Review.


http://www.learningmarkets.com/index.php/200911178777/News-Feed/News-Feed/poniard-pharmaceuticals-inc-endures-analyst-downgrade-pard-ilmn-genz.html